Differences between the RA and control groups regarding FLS protein expression and location were determined by performing immunostaining against CDH11 (5), a typical FLS marker, and pPDGFRαβ, which increases specifically in the synovium of RA and is positive in RA-FLS (17). Here, CDH11 is linked to rheumatoid arthritis.